eISSN: 1509-572x
ISSN: 1641-4640
Folia Neuropathologica
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2006
vol. 44
 
Share:
Share:

Original article
Changes of cytoskeletal proteins in ischaemic brain under cardiac arrest and reperfusion conditions

Grzegorz Sulkowski
,
Lidia Strużyńska
,
Aleksandra Lenkiewicz
,
Urszula Rafałowska

Online publish date: 2006/06/23
Article file
- Changes.pdf  [0.35 MB]
Get citation
 
 

Introduction
Our previous study indicated that global brain ischaemia caused by cardiac arrest and reperfusion produced disturbances in energy metabolism and transfer of information (uptake, release, and binding of neurotransmitters by specific receptors) in the central nervous system (CNS) [20,27,28]. It is known that calpains are normally involved in intracellular signal transduction and synaptic plasticity, but they are also implicated in ischaemic brain injury. However, an earlier study concerns of calpains and other cytosceletal proteins were carried out in a gerbil model of transient ischaemia or postdecapitative ischaemia [29,31]. Up to now, there have been no reports about the effect of cardiac arrest and reperfusion on calpains. Therefore we examined the nature of alterations in the level of calpains and its preferred substrates, cytosceletal proteins MAP-2 and fodrin, immediately after cardiac arrest and in several post-resuscitation times. In order to investigate the level and activity of calpains, we tested its immunoreactivity in relation to the changes in the level of MAP-2, and to the appearance of 150-kDa α-fodrin breakdown product (FBDP), which is a marker of proteolytic activity of enzyme.
Material and methods

Materials
Antibodies: rabbit polyclonal anti-spectrin (fodrin) and rabbit polyclonal anti-calpain II from Chemicon, mouse monoclonal anti-MAP-2 from Sigma, anti-rabbit or anti-mouse IgG conjugated with horseradish peroxidase from Sigma; hybond-C membranes and the ECL Western blotting detection kit from Amersham Life Science (Buckinghamshire, UK); prestained protein marker, acrylamide and bis-acrylamide from Bio-Rad (Richmond, CA, USA). All other consumables were purchased from standard commercial sources and were of the highest purity available.
Experimental procedures
Male Wistar rats of 150-200 g body weight were used for the study. All procedures were in compliance with the NIH Guide for the care and use of laboratory animals and were approved by the local Animal Care Committee. The technique of cardiac arrest and reperfusion was that of Korpachev et al. [9] as described by Pluta et al. [18]. Briefly, animals were anaesthetized and a special blunt-end, hook-like metal probing device was inserted into the chest cavity through the third intercostals space, and manipulated to occlude the heart and great vessel bundle against the compressed sternum to produce ventricular arrest. After 2.5-3.5 min, the probe was removed. Resuscitation was started 10 min after global ischaemia and consisted of external chest compression until spontaneous heart function and respiration occurred. During this time, atmospheric air was pumped through a polyethylene tracheal tube connected to a mechanical ventilator. Spontaneously breathing animals were returned to their cages for recovery.
Experimental design
Five different experimental groups of animals were used. Group I, non-ischaemic, control sham-operated animals in which the probe was inserted into the chest cavity under anesthesia, but without further manipulation and torsion; Group II, 10 min cardiac arrest, global ischaemia; Group III, 10 min global ischaemia + 1 h resuscitation and reperfusion; Group IV, 10 min global ischaemia + 24 h resuscitation and reperfusion; and Group V, 10 min global ischaemia + 7 days reperfusion. Five animals from each group were decapitated, brains quickly removed and placed in cold isolating medium (0.32 M sucrose, 1 mM EDTA, 10 mM Tris HCl, pH 7.4) to obtain homogenates. Another 3 rats from each group were sacrificed for electron microscopic studies. In deep anesthesia, they were perfused through the heart with 0.9% saline chloride and subsequently with a fixative solution (2% paraformaldehyde, 2.5% glutaraldehyde, 0.1 M cacodylate buffer pH 7.4) and decapitated. Brains were prepared according to the procedure described below.
Electron microscopic studies
After additional fixation in the above mentioned fixative solution, small specimens of forebrains were then fixed in 1.5% OsO4 and 0.8% K4(FeCN)6 for 2 h. Subsequently, after dehydration in ethanol and propylene oxide, the material was embedded in Spurr resin and ultrathin sections were examined in JEM 1200Ex electron microscope. In each experimental group, 15 random electron micrographs were taken from three different animals (total number of micrographs n = 45). The morphometric analysis of ultrastructural changes (counting a number of synaptic vesicles in synapses) was done using the Multiscan computer program and the results were evaluated statistically.
Western blotting procedure
Brain homogenate samples (20 µg protein) were mixed with an equal volume of concentrated (x 2) Laemmli buffer and heated to 95°C for 5 min. Samples were subjected to 10% SDS-PAGE electrophoresis, and then transblotted onto the nitrocellulose membrane. After blocking with 5% milk in TPBS buffer, blots were incubated with commercially available primary monoclonal or polyclonal antibodies, (diluted 1:250 for calpain and fodrin, and 1: 500 for MAP-2) for 2 h. After washing three times with TPBS, blots were incubated with secondary antibodies conjugated with HRP (1:4000). Bands were detected with the ECL kit (Amersham) and exposed for 20-40 min to Hyperfilm ECL (Amersham). Densitometric analysis of band patterns was performed using UltraScanTMXL (Pharmacia).
Protein determination
The protein concentration was measured according to the method of Lowry et al. [14] using bovine serum albumin as a standard.
Statistical analysis
Data are presented as means±SD from three to five experiments as stated in the figure legends. The statistical analysis was performed by one-way ANOVA. Post-hoc Dunnett’s multiple comparison test was used to identify data significantly different from control values (*P<0.05, **P<0.01).
Results

The effect of cardiac arrest andreperfusion on the number of synaptic vesicles in rat brain
The electron microscopic studies of synapses from control rat brains (group I) did not show any abnormalities. Synaptosomal vesicles were densely packed and mitochondria showed normal morphology (Fig. 1A). Ten minutes cardiac arrest (group II) and early reperfusion (1 and 24 h post resuscitation, groups III and IV, respectively) caused a significant reduction of synaptic vesicles number (Fig. 1B, C). Additionally, the disturbances in mitochondria structure were observable, especially in the density of the mitochondrial matrix and in the integrity of internal mitochondrial membrane. The number of synaptic vesicles after 10 min global ischaemia and 1 and 24 h post resuscitation decreased by about 56% compared to controls. After 7 days post resuscitation (group V) synapses did not differ from respective controls in the synaptic vesicles number and morphology of mitochondria (Fig. 1D).
The effect of cardiac arrest and reperfusion on the level of calpain and cytosceletal components Calpain
We did not observe changes in protein expression of calpain just after 10 min global ischaemia caused by cardiac arrest (group II). However, distinct differences were seen in brains of rats recovered after ischaemia. Enhanced expression of enzyme’s protein was found in all those groups i.e. 20%, 128%, 133% over control values in III, IV, and V group, respectively (Fig. 2).
MAP 2
We observed a reduction in MAP-2 immunoreactivity in all groups of experimental animals (groups II-IV), except that with 7 days post resuscitation (group V). The protein level was markedly decreased below control 60%, 65%, and 55%, in respective time periods after ischaemic insult. Representative immunoblot displaying the levels of MAP-2 in the brain homogenate after global cerebral ischaemia caused by cardiac arrest and during reperfusion is shown in Fig. 3.
Fodrin
Immunostaining of 150-kDa proteolytic fragment of fodrin, which is a marker of calpain proteolysis is shown in Fig. 4. In the brains from control animals (group I) and after 10 min cardiac arrest (group II) immunoreactivity of bands was of similar intensity. Intensity of 150-kDa bands staining, which corresponds to α-fodrin breakdown product (FBDP), increased gradually in the remaining groups of animals (III, IV and V) and reached 25%, 110%, and 150% of control level, respectively.
Discussion
The experiments presented in the work were conducted to obtain information on the temporal changes in calpain and cytoskeleton building proteins in the brain during cardiac arrest and reperfusion in connection with the transport of synaptic vesicles. We chose the model of cardiac arrest and reperfusion proposed by Korpachev et al. [9] as this seemed to be well controllable and accurately mimics global ischaemia under cardiac arrest and reperfusion in human [18]. Results of our previous study, conducted using the same experimental model, indicated clearly that ischaemic and early reperfusion conditions after cardiac arrest lead to a reduction in oxygen consumption, decrease of ATP/ADP ratio, disturbances of synaptic mitochondria structure [28]. We observed also changes in neurotransmitters (GABA and dopamine) uptake and release and in dopamine D2 and GABAB receptors [20,27]. These investigations showed that global ischaemia resulting from cardiac arrest and short times after resuscitation lead to the selective injury (of energetic nature) of synapses resulting in disturbances of neurotransmitters’ transport [20,27,28]. However, calpain-mediated cytoskeletal degradation may be also responsible for dysfunctions in neurotransmission during ischaemia [1-3,5,8,21,22] and in vivo administration of calpain’s inhibitors has been shown to be neuroprotective [6,12,30]. Thus, we have studied the nature of changes in calpain and its substrates in the brain under cardiac arrest and reperfusion conditions. The enhancement of calpain’s protein level was observed in our experiment as early as 1 h after ischaemia, and increased continuously during reperfusion. This finding fits well to the hypothesis postulated by Siesjö et al. [24] that shows correlation between increased Ca2+ concentration, calpain activation and postischaemic injury. We also noticed a significant degradation of cytoskeletal proteins, MAP-2 and fodrin, recognized as a preferred calpain’s substrates [16,26], which accompanied the elevation of calpain’s protein. Similar postischaemic changes in the level and activity of calpain; breakdown of fodrin in dendritic processes and in nerve endings were recently reported in a gerbil model of transient ischaemia and in a model of postdecapitative ischaemia in the rat [4,17,32]. The activation of calpain, leading to the proteolysis of fodrin and MAP’s may play an important role in synaptosomal function [5]. It was proposed that calpain-mediated proteolysis of cytoskeletal proteins is involved in long-term potentiation through excitatory amino acid-induced Ca2+ influx into synapses [10,13,19,23], and also in exocytosis. Fodrin (or brain spectrin) indirectly cross links and attaches actin filaments to the plasma membrane [7,11,25]. Additionally, with fodrin interacts synapsin I (a major synaptic constituent) which may modulate neurotransmitter release [7]. Hence, it could be expected that alterations in the cytoskeleton building proteins may reflect disintegration of cytoskeleton that further may interfere directly or indirectly with the process of proper formation and transport of synaptic vesicles. Marked ultrastructural abnormalities in brain synapses reported here, are in coincidence with the observed changes in fodrin and MAP-2. Progression of such local changes in the synaptic region has an effect on neurotransmission, signal transduction processes and can produce destruction nerve endings or even cell bodies. Calpain has been implicated in the activation and down-regulation of protein kinase C after transient cerebral ischaemia [32]. Thus, calpain activation in the synapses may modulate transport of synaptic vesicles, and neuronal transmission possibly through the cytoskeletal proteins (fodrin and MAPs) proteolysis or the activation of the intracellular signal transduction system [5,7]. As evident from our findings, in the applied model of cardiac arrest cause global cerebral ischaemia, calpain-mediated breakdown of fodrin may be an early feature of neuronal damage, and the loss of MAP-2 provides a sensitive means for detecting the time-dependent degradation of cytoskeleton components and disturbed transport of neuronal vesicles. These findings are in accordance with our earlier study [20,27] and those of Matesic and Lin [15] observed in gerbils. From these results it can be speculated that cardiac arrest and recovery may lead to disturbances in the CNS among others by interfering with calpain, which is involved in regulation of a variety of function including locomotion, neurotransmission, and neuroendocrine secretion. Enhanced activity of this enzyme, due to the neuronal cytoskeleton degradation, may be one of the reasons of disturbances in transport of neurotransmitters. Inhibition of calpain activity may be, for sure, a promising strategy for alleviating damages after cardiac infarct and reperfusion.
Acknowledgements
This work was supported by a statutable grant from the State Committee for Scientific Research to the Medical Research Centre, Polish Academy of Sciences. The authors are grateful to Dr M. Walski for help in electron microscope study and Mr. S. Januszewski for technical assistance.
References
1. Bartus RT, Elliott PJ, Hayward NJ, Dean RL, Harbeson S, Straub JA, Li Z, Powers JC. Calpain as a novel target for treating acute neurodegenerative disorders. Neurol Res 1995; 17: 249-258. 2. Blomgren K, Kawashima S, Saido TC, Karlson JO, Elmered A, Hagberg H. Fodrin degradation and subcellular distribution of calpains after neonatal rat cerebral hypoxic-ischemia. Brain Res 1995; 684: 143-149. 3. Blomgren K, McRae A, Bona E, Saido T, Karlson JO, Hagberg H. Degradation of fodrin and MAP 2 after neonatal cerebral hypoxic-ischemia. Brain Res 1995; 684: 136-142. 4. Domanska-Janik K, Zalewska T, Zablocka B, Ostrowski J. Ischemia-induced modifications of protein components of rat brain postsynaptic densities. Neurochem Int 1999; 34: 329-336. 5. Fukuda S, Harada K, Kunimatsu M, Sakabe T, Yoshida K. Postischemic reperfusion induces alphα-fodrin proteolysis by m-calpain in the synaptosome and nucleus in rat brain. J Neurochem 1998; 70: 2526-2532. 6. Hong SC, Goto Y, Lanzino G, Soleul S, Kassell NF, Lee KS. Neuroprotection with an calpain inhibitor in a model of focal cerebral ischemia. Stroke 1994; 25: 663-669. 7. Iga M, Inui M, Sobue K. Characterization of the interaction between synapsine I and calspectin (brain spectrin or fodrin). Biochem Biophys Res Commun 1997; 231: 852-855. 8. Kogure K, Arai H, Abe K, Nakano M. Free radical damage of the brain following ischemia. Prog Brain Res 1985; 63: 237-259. 9. Korpachev VG, Lysenkov SP, Tel’ LZ. Modeling clinical death and postresuscitation disease in rats. Patolog Fiziol Eksp Ter 1982; 3: 78-80 (in Russian). 10. Kozuka M. Changes in brain energy metabolism, neurotransmitters, and choline during and after incomplete ischemia in spontaneously hypertensive rats. Neurochem Res 1995; 20: 23-30. 11. Levine J, Willard M. Fodrin: axonally transported polypeptides associated with the internal periphery of many cells. J Cell Biol 1981; 90: 631-642. 12. Li PA, Howlett W, He QP, Miyashita H, Siddiqui M, Shuaib A. Postischemic treatment with calpain inhibitor MDL 28170 ameliorates brain damage in a gerbil model of global ischemia. Neuroscien Lett 1998; 247: 17-20. 13. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999; 79: 1431-1568. 14. Lowry OH, Rosebrough NJ, Far AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265-275. 15. Matesic DF, Lin RCS. Microtubule-associated protein 2 as an early indicator of ischemia-induced neurodegeneration in the gerbil forebrain. J Neurochem 1994; 63: 1012-1020. 16. Melloni E, Pontremoli S. The calpains. Trends Neurosci 1989; 12: 438-444. 17. Neumar RW, Meng FH, Mills AM, Xu YA, Zhang C, Welsh FA, Siman R. Calpain activity in the rat brain after trensistent forebrain ischemia. Exp Neurol 2001; 170: 27-35. 18. Pluta R, Lossinsky AS, Mossakowski MJ, Faso L, Wisniewski HM. Reassessment of a new model of complete cerebral ischemia in rats. Method of induction of clinical death, pathophysiology and cerebrovascular pathology. Acta Neuropathol (Berl) 1991; 83: 1-11. 19. Pluta R, Saliñska E, Puka M, Stafiej A, £azarewicz JW. Early changes in extracellular amino acids and calcium concentrations in rabbit hippocampus following complete 15-min cerebral ischemia. Resuscitation 1988; 16: 193-210. 20. Rafa³owska U, Sulkowski G, Waœkiewicz J, Januszewski S, Kapuœciñski A. Alteration of dopamine transport and dopamine D2 receptor binding in the brain induced by early and late consequences of global ischaemia caused by cardiac arrest in the rat. Resuscitation 2000; 47: 195-201. 21. Safar P. Cerebral resuscitation after cardiac arrest: a review. Circulation 1986; 74: 138-153. 22. Seubert P, Lee K, Lynch G. Ischemia triggers NMDA receptor-linked cytoskeletal proteolysis in hippocampus. Brain Res 1989; 492: 366-370. 23. Siesjo B, Bengtsson F. Calcium fluex, calcium antagonist, and calcium-related pathology in brain ischemia, hypoglycemia and spreading depression: a unifying hypothesis. J Cereb Blood Flow Metab 1989; 9: 127-140. 24. Siesjo BK, Elmer E, Janelidze S, Keep M, Kristian T, Ouyang YB, Uchino H. Role and mechanisms of secondary mitochondrial failure. Acta Neurochirurgica 1999; 73 (supl.): 7-13. 25. Siman R, Baudry H, Lynch G. Brain fodrin: substrate for calpain I, an endogenous calcium activated protease. Proc Natl Acad Sci USA 1984; 81: 3572-3576. 26. Siman R, Noszek JC. Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron 1988; 1: 279-287. 27. Sulkowski G, Waśkiewicz J, Januszewski S, Rafałowska U. Alteration of GABA transport and GABAB receptor in the brain induced by early and late consequences of global ischaemia caused by cardiac arrest in the rat. Folia Neuropathol 2001; Suppl A: 25-31. 28. Sulkowski G, Waśkiewicz J, Walski M, Januszewski S, Rafałowska U. Synaptosomal susceptibility on global ischaemia caused by cardiac arrest correlated with early and late times recirculation in rats. Resuscitation 2002; 52: 203-213. 29. Suzuki K, Ohno S. Calcium activated neutral protease-structure-function relationship and functional implications. Cell Struct Funct 1990; 15: 1-6. 30. Yokota M, Tani E, Tsubuki S, Yamaura I, Nakagaki I, Hori S, Saido TC. Calpain inhibitor entrapped in liposomes rescues ischemic neuronal damage. Brain Res 1999; 819: 8-14. 31. Zalewska T, Zablocka B, Saido TC, Zajac H, Domanska-Janik K. Dual response of calpain to rat brain postdecapitative ischemia. Mol Chem Neuropathol 1998; 33: 185-197. 32. Ziemka-Nalecz M, Zalewska T, Zajac H, Domanska-Janik K. Decrease of PKC precedes other cellular signs of calpain activation in area CA1 of the hippocampus after transient cerebral ischemia. Neurochem Int 2003; 42: 205-214.
Copyright: © 2006 Mossakowski Medical Research Centre Polish Academy of Sciences and the Polish Association of Neuropathologists. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.